Tech Company Financing Transactions

Crescendo Health Funding Round

Crescendo Health closed a $3.4 million venture capital round on 1/5/2023. Investors included Define Ventures.

Transaction Overview

Company Name
Announced On
1/5/2023
Transaction Type
Venture Equity
Amount
$3,400,000
Round
Undisclosed
Investors

Define Ventures (Lead Investor)

Proceeds Purpose
Crescendo Health plans to scale its services throughout the life sciences industry and will use the investment to build software tools that will enable its clients to research the longitudinal effects of treatments and track outcomes over time.

Company Information

Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
18 Bartol St 980
San Francisco, CA 94133
USA
Phone
Undisclosed
Email Address
Overview
Crescendo was founded by Sam Roosz and Michael Glassman to enable better health outcomes for patients, while protecting the interests of research participants. This means bringing world-leading technologies in data security to clinical research and ensuring that every member of the Crescendo team feels proud to have our products deployed as part of future care for our loved ones. As a public benefit corporation, our corporate structure enables decisions that prioritize societal impact. We're here to enable research that is far more accessible to patients and clinicians, so that the costs of new research fall precipitously, and there are pathways to efficiently monitor the long-term safety and efficacy of new treatments.
Profile
Crescendo Health LinkedIn Company Profile
Social Media
Crescendo Health Company Twitter Account
Company News
Crescendo Health News
Facebook
Crescendo Health on Facebook
YouTube
Crescendo Health on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Sam Roosz
  Sam Roosz LinkedIn Profile  Sam Roosz Twitter Account  Sam Roosz News  Sam Roosz on Facebook
Chief Medical Officer
Mark Cullen
  Mark Cullen LinkedIn Profile  Mark Cullen Twitter Account  Mark Cullen News  Mark Cullen on Facebook
President
Michael Glassman
  Michael Glassman LinkedIn Profile  Michael Glassman Twitter Account  Michael Glassman News  Michael Glassman on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/5/2023: HighTide Therapeutics venture capital transaction
Next: 1/5/2023: Perspectum venture capital transaction

 

Share this article

 


About Database of VC Transactions

We report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary